--- title: "Hvsen Biotech released its first-quarter performance, turning a loss into a profit of 44.497 million yuan" type: "News" locale: "en" url: "https://longbridge.com/en/news/237903689.md" description: "According to the Zhitong Finance APP, Hvsen Biotech released its first-quarter report for 2025, with operating revenue of 399 million yuan, a year-on-year increase of 92.96%. The net profit attributable to shareholders of the listed company was 44.497 million yuan. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 34.0907 million yuan. The basic earnings per share were 0.2684 yuan" datetime: "2025-04-28T16:47:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/237903689.md) - [en](https://longbridge.com/en/news/237903689.md) - [zh-HK](https://longbridge.com/zh-HK/news/237903689.md) generator: "portal-rs" --- # Hvsen Biotech released its first-quarter performance, turning a loss into a profit of 44.497 million yuan According to the Zhitong Finance APP, Hvsen Biotech (300871.SZ) released its first quarter report for 2025, with operating revenue of 399 million yuan, a year-on-year increase of 92.96%. The net profit attributable to shareholders of the listed company was 44.497 million yuan. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 34.0907 million yuan. The basic earnings per share were 0.2684 yuan ### Related Stocks - [300871.CN](https://longbridge.com/en/quote/300871.CN.md) ## Related News & Research - [LaSalle Capital completes investment in Cheesemakers](https://longbridge.com/en/news/298369510.md) - [NFL Biosciences flags CESTO2 post-hoc analysis on NFL-101 smoking-cessation biomarker at SFT congress](https://longbridge.com/en/news/298271560.md) - [Sipef agrees to buy Côte d'Ivoire banana plantation Tiabam from Agribam](https://longbridge.com/en/news/298167074.md) - [Freeman Gold starts baseline vegetation, ecosystem surveys at Lemhi Gold project in Idaho](https://longbridge.com/en/news/298310714.md) - [Alembic Pharmaceuticals Sets Up Wholly Owned Subsidiary in Dubai to Drive Global Expansion](https://longbridge.com/en/news/298223880.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**